A double blind, multicentre, placebo controlled trial of lornoxicam in patients with osteoarthritis of the hip and knee.

Lornoxicam is a new non-steroidal anti-inflammatory agent (NSAID) with a similar pharmacological profile to other oxicams and a potency 10 times greater than piroxicam. A multicentre, randomised, double blind, parallel group study was undertaken to compare the efficacy and tolerance of four weeks�...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Berry, H, Bird, H A, Black, C, Blake, D R, Freeman, A M, Golding, D N, Hamilton, E B, Jayson, M I, Kidd, B, Kohn, H
Formato: Artigo
Lenguaje:Inglês
Publicado: 1992
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1005665/
https://ncbi.nlm.nih.gov/pubmed/1550410
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares